JANSSEN PHARMACEUTICALS, INC. et al v. HIKMA PHARMACEUTICALS USA INC.

Docket(#17) ANSWER to Counterclaim by All Plaintiffs.(MILLER, KEITH) (Entered: 07/28/2023)

Docket(#16) TEXT ORDER: The Court having received the July 21, 2023 letter submitted by Keith J. Miller, Esquire [ECF No. 15], counsel for Plaintiff; it is hereby ORDERED that the initial conference scheduled for August 15, 2023 is RESCHEDULED to September 27, 2023 at 11:30 a.m. Counsel shall utilize the following dial-in instructions for the conference: 1-888-278-0296, Access Code 2961061#. So Ordered by Magistrate Judge Sharon A. King on 7/25/23. (mb, ) (Entered: 07/25/2023)

Docket(#15) Letter from Keith J. Miller, Esq. to Hon. Sharon A. King, U.S.M.J. Requesting Adjournment of Initial Scheduling Conference. (MILLER, KEITH) (Entered: 07/21/2023)

Docket(#14) TEXT ORDER: The initial scheduling conference on August 15, 2023 at 10:00 am shall be held VIA TELEPHONE. Counsel shall utilize the following dial-in instructions for the conference 1-888-278-0296 Access code 2961061#. Additionally, the joint discovery plan shall be filed on the docket. So Ordered by Magistrate Judge Sharon A. King on 7/11/23. (mb, ) (Entered: 07/11/2023)

Docket(#13) Order Initial Conference set for 8/15/2023 at 10:00 AM via Teleconference before Magistrate Judge Sharon A. King. Signed by Magistrate Judge Sharon A. King on 7/10/2023. (alb, ) (Entered: 07/10/2023)

Docket(#12) Corporate Disclosure Statement by HIKMA PHARMACEUTICALS USA INC.. (RICHTER, JAMES) (Entered: 07/07/2023)

Docket(#11) ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC. by HIKMA PHARMACEUTICALS USA INC..(RICHTER, JAMES) (Entered: 07/07/2023)

DocketSet Deadlines as to #10 MOTION for Leave to Appear Pro Hac Vice on Consent. Motion set for 8/7/2023 before Magistrate Judge Sharon A. King. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (alb, ) (Entered: 07/07/2023)

Docket(#10) MOTION for Leave to Appear Pro Hac Vice on Consent by HIKMA PHARMACEUTICALS USA INC.. (Attachments: #1 Declaration of James Richter, #2 Declaration of C. Klein, #3 Declaration of J. Wong, #4 Declaration of D. Dalke, #5 Declaration of A. Graham, #6 Text of Proposed Order)(RICHTER, JAMES) (Entered: 07/06/2023)

DocketSet Deadlines as to #9 MOTION for Leave to Appear Pro Hac Vice . Motion set for 8/7/2023 before Magistrate Judge Sharon A. King. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (alb, ) (Entered: 06/30/2023)

Docket(#8) STIPULATION AND ORDER Dismissing without prejudice defendants HIKMA PHARMACEUTICALS PLC and WEST-WARD COLUMBUS INC. and amending caption. The time for HIKMA PHARMACEUTICALS USA INC. to answer or otherwise respond to Plaintiffs' complaint is extended until 7/7/2023. Signed by Judge Karen M. Williams on 6/15/2023. (jab) (Entered: 06/15/2023)

Docket(#7) Letter from Michael J. Gesualdo, Esq. to Hon. Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulation and Order. (Attachments: #1 Text of Proposed Order)(GESUALDO, MICHAEL) (Entered: 06/14/2023)

Docket(#6) NOTICE of Appearance by JAMES S. RICHTER on behalf of HIKMA PHARMACEUTICALS USA INC. (RICHTER, JAMES) (Entered: 06/13/2023)

Docket(#5) SUMMONS Returned Executed by JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV. HIKMA PHARMACEUTICALS USA INC. served on 6/2/2023, answer due 6/23/2023. (MILLER, KEITH) (Entered: 06/06/2023)

Docket(#4) AO120 Patent/Trademark Form filed. (ssp, ) (Entered: 06/01/2023)

Docket(#3) SUMMONS ISSUED as to HIKMA PHARMACEUTICALS PLC, HIKMA PHARMACEUTICALS USA INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, ) (Entered: 06/01/2023)

DocketNotice of Judicial Preferences. #Click here for the Judge's Individual Procedure Requirements. (ssp, ) (Entered: 06/01/2023)

Docket(#2) Corporate Disclosure Statement by JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC. identifying Johnson & Johnson as Corporate Parent.. (MILLER, KEITH) (Entered: 05/31/2023)

DocketJudge Karen M. Williams and Magistrate Judge Sharon A. King added. (dmw) (Entered: 05/31/2023)

Docket(#1) COMPLAINT against HIKMA PHARMACEUTICALS PLC, HIKMA PHARMACEUTICALS USA INC., WEST-WARD COLUMBUS INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14351927) , Related Case Selected, filed by JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(MILLER, KEITH) (Entered: 05/30/2023)